{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Highly resistant variants of COVID-19 continue to emerge\",\"Impact\":\"Prolonged pandemic with ongoing waves of infection\",\"Mitigation\":\"Vaccination campaigns targeting variants, development of new treatments, and strict public health measures\",\"Technologies\":\"Genomic surveillance for early detection of new variants, mRNA technology for vaccine development\",\"People\":\"General public, healthcare workers, vulnerable populations\",\"Owner\":\"Public health authorities, pharmaceutical companies, research institutions\"},{\"Description\":\"Asymptomatic infections pose a challenge for disease control\",\"Impact\":\"Unrecognized spread of the virus, difficulty in containment and isolation of infected individuals\",\"Mitigation\":\"Development of rapid and accurate diagnostic tests, implementation of regular surveillance and testing protocols, public health education on asymptomatic transmission\",\"Technologies\":\"Rapid antigen tests, PCR-based diagnostic assays, mobile health apps for self-reporting symptoms\",\"People\":\"General public, healthcare workers, individuals in close contact with high-risk groups\",\"Owner\":\"Healthcare organizations, public health agencies, technology companies\"},{\"Description\":\"Ineffectiveness of routine symptom screening for COVID-19\",\"Impact\":\"Failure to identify infected individuals, potential for continued transmission within communities\",\"Mitigation\":\"Implementation of more reliable diagnostic methods, education on atypical symptoms, and increased testing frequency\",\"Technologies\":\"Rapid antigen tests, PCR-based diagnostic assays, advanced symptom tracking apps\",\"People\":\"Workplace and school communities, individuals in close contact with others\",\"Owner\":\"Employers, school administrations, public health agencies\"}]}"}}